Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Cellular Physiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10199559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene.

  1997cited by this paper
• Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion.

  1997cited by this paper
• Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes.

  1996cited by this paper
• Insulin-like growth factor binding proteins in fetal rat mesencephalic cultures: regulation by fibroblast growth factor and insulin-like growth factor I.

  1996cited by this paper
• A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.

  1996cited by this paper
• Synthesis of insulinlike growth factor binding proteins and of the acid‐labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: Regulation by insulin, insulinlike growth factor, and growth hormone

  1996cited by this paper
• Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.

  1996cited by this paper
• Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta.

  1996cited by this paper
• Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

  1995cited by this paper
• Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT.

  1995cited by this paper
• Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.

  1995cited by this paper
• Identification of insulin‐like growth factor binding proteins from cultured human epidermal keratinocytes

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.

  1995cited by this paper
• Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.

  1994cited by this paper
• A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action.

  1994cited by this paper
• Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I.

  1994cited by this paper
• A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

  1994cited by this paper
• IGF-binding proteins are differentially regulated in an ovarian granulosa cell line.

  1994cited by this paper
• Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization.

  1994cited by this paper
• IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells.

  1994cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production.

  1993cited by this paper
• Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth.

  1993cited by this paper
• Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.

  1993cited by this paper
• TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds.

  1993cited by this paper
• Release of fibroblast IGFBPs by TGF-beta and IGF-I occurs through distinct mechanisms.

  1993cited by this paper
• In vitro paracrine regulation of human keratinocyte growth by fibroblast‐derived insulin‐like growth factors

  1992cited by this paper
• Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin.

  1992cited by this paper
• Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.

  1992cited by this paper
• The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor

  1992cited by this paper
• Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6).

  1991cited by this paper
• Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts.

  1991cited by this paper
• Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor.

  1991cited by this paper
• Cloning and expression of human insulin-like growth factor binding protein 3.

  1990cited by this paper
• Effects of insulin-like growth factors on protein metabolism: why are some molecular variants more potent?

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

  1986cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Hyperpigmentation in a Chinese family with autosomal dominant Cole disease

  2021cites this paper
• A novel ENPP1 mutation identified in a multigenerational family affected by Cole disease

  2020cites this paper
• The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease

  2020cites this paper
• Survey of Apoptosis After Hypothermic Storage of a Pancreatic β-Cell Line

  2016cites this paper
• Genome-scan analysis for genetic mapping of quantitative trait loci underlying birth weight and onset of puberty in doe kids (Capra hircus).

  2014cites this paper
• Development of Pancreas Storage Solutions: Initial Screening of Cytoprotective Supplements for β-Cell Survival and Metabolic Status after Hypothermic Storage

  2013cites this paper
• The roles of MUC1 and EGFR in breast cancer progression and mammary lactation

  2013cites this paper
• Cole Disease Results from Mutations in ENPP1.

  2013cites this paper
• Gene-expression profiles of epithelial cells treated with EMD in vitro: analysis using complementary DNA arrays.

  2011cites this paper
• IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin*

  2010cites this paper
• Insulin-like growth factor-binding protein-2 and -3 in gingival crevicular fluid.

  2010cites this paper
• Glycemic Index, Glycemic Load: New Evidence for a Link with Acne

  2009cites this paper
• Glycemic index, glycemic load, wellness and beauty: the state of the art.

  2009cites this paper
• IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms

  2007cites this paper
• Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium.

  2007cites this paper
• Amino‐terminal deletion of heparin‐binding epidermal growth factor‐like growth factor4−127 stimulates cell proliferation but lacks insulin‐like activity

  2007cites this paper
• Polymorphism in the epidermal growth factor gene is associated with birthweight in Sinhalese and white Western Europeans.

  2007cites this paper
• Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.

  2007cites this paper
• EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I.

  2006cites this paper
• Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA

  2005cites this paper
• UV induced responses of the human epidermal IGF system: Impaired anti-apoptotic effects of IGF-I in HaCaT keratinocytes

  2005cites this paper
• Insulin‐like growth factor binding protein‐3 (IGFBP‐3) localizes to and modulates proliferative epidermal keratinocytes in vivo

  2005cites this paper
• EGF-mediated regulation of insulin-like growth factor binding protein ( IGFBP )-3 determines esophageal epithelial cellular response to IGF-I

  2005cites this paper
• Differential Expression of TGF-β Isoforms During Differentiation of HaCaT Human Keratinocyte Cells: Implication for the Separate Role in Epidermal Differentiation

  2004cites this paper
• Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3

  2004cites this paper
• Insulin-like growth factor-binding protein-3 in porcine ovarian granulosa cells: gene cloning, promoter mapping, and follicle-stimulating hormone regulation.

  2004cites this paper
• Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems.

  2003cites this paper
• Hyperinsulinemic diseases of civilization: more than just Syndrome X.

  2003cites this paper
• Transgenic and knock-out mice for deciphering the roles of EGFR ligands

  2003cites this paper
• Successful Six‐Day Kidney Preservation Using Trophic Factor Supplemented Media and Simple Cold Storage

  2002cites this paper
• Acne vulgaris: a disease of Western civilization.

  2002cites this paper
• Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT.

  2001cites this paper
• IGFBP-3 and apoptosis—a licence to kill?

  2001cites this paper
• The effect of epidermal growth factor and IGF-I infusion on hepatic and renal expression of the IGF-system in adult female rats.

  2000cites this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cites this paper
• Expression of Epidermal Growth Factor in Transgenic Mice Causes Growth Retardation*

  2000cites this paper
• Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3

  2000cites this paper